Patent · US Active

Selective inhibition of gluconeogenic activity

US11247970B2 · kind B2 · utility

0Cited by

3References

13Claims

0Family size

Assignees

DANA-FARBER CANCER INSTITUTE, INC. · US
THE SCRIPPS RESEARCH INSTITUTE · US
The Broad Institute, Inc. · US

Inventors

Pere Puigserver · Brookline, US
Kfir Sharabi · Watertown, US
Theodore Kamenecka · North Palm Beach, US
Patrick R. Griffin · North Palm Beach, US
Stuart L. Schreiber · Cambridge, US
Roger Schilling · Chesterfield, US
Partha P. Nag · Somerville, US
Joshua A. Bittker · Cambridge, US

Key dates

Filing date	Mar 21, 2018
Grant date	Feb 15, 2022
Priority date	—
Expiry date	Mar 21, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds, pharmaceutical compositions and methods for treating and/or preventing a metabolic condition, such as diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.